Literature DB >> 14656195

Cancer-related fatigue.

Constance Visovsky1, Susan M Schneider.   

Abstract

Approximately 1.3 million people in the United States will be diagnosed with cancer in 2003 and millions of other individuals are already living with the disease. Fatigue continues to be the most prevalent and disruptive symptom of cancer and its treatment regimens. Fatigue was the most frequent and distressing cancer-related symptom occurring in women with lung cancer, two times greater than the next symptom, pain, and remains one of the most common symptoms in newly diagnosed lung cancer patients at any stage of the disease. There are many causes of cancer-related fatigue including preexisting conditions, physical and psychological symptoms caused by cancer, and the consequences of cancer treatment. High levels of fatigue decrease quality of life, physical functional status, and symptom management. This article presents an evidenced-base review of cancer-related fatigue, strategies for the management of cancer-related fatigue, and recommendations for clinical practice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656195

Source DB:  PubMed          Journal:  Online J Issues Nurs        ISSN: 1091-3734


  8 in total

1.  Fatigue in gynaecological cancer patients: a pilot study.

Authors:  G Prue; J Rankin; F Cramp; J Allen; J Gracey
Journal:  Support Care Cancer       Date:  2005-05-10       Impact factor: 3.603

2.  Virtual reality: a distraction intervention for chemotherapy.

Authors:  Susan M Schneider; Linda E Hood
Journal:  Oncol Nurs Forum       Date:  2007-01       Impact factor: 2.172

3.  Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels.

Authors:  Marcella Daniel; Francis J Keefe; Pauline Lyna; Bercedis Peterson; Jennifer Garst; Mike Kelley; Gerold Bepler; Lori A Bastian
Journal:  J Pain       Date:  2009-03       Impact factor: 5.820

Review 4.  Speed of haemoglobin response in patients with cancer: a review of the erythropoietic proteins.

Authors:  Carsten Oberhoff
Journal:  Support Care Cancer       Date:  2007-02-03       Impact factor: 3.359

5.  Endurance and Resistance Training in Radically Treated Respiratory Cancer patients: A Pilot Study.

Authors:  B Salhi; I Demedts; A Simpelaere; S Decraene; K Vermaelen; V Surmont; J P van Meerbeeck; E Derom
Journal:  Rehabil Res Pract       Date:  2010-08-05

6.  ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass.

Authors:  Rafael Barreto; Yukiko Kitase; Tsutomu Matsumoto; Fabrizio Pin; Kyra C Colston; Katherine E Couch; Thomas M O'Connell; Marion E Couch; Lynda F Bonewald; Andrea Bonetto
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

Review 7.  Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition.

Authors:  Fabrizio Pin; Marion E Couch; Andrea Bonetto
Journal:  Curr Opin Support Palliat Care       Date:  2018-12       Impact factor: 2.302

8.  Gender Differences in Quality of Life of Metastatic Lung Cancer Patients.

Authors:  Myriam Koch; Frederike Rasch; Tobias Rothammer; Karolina Müller; Arno Mohr; Michael Koller; Christian Schulz
Journal:  Cancer Manag Res       Date:  2022-10-11       Impact factor: 3.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.